Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Minoxidil effectively treats female pattern hair loss.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Menopause affects hair and skin; more research needed for treatment.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Treatment during development affects hormone balance and sexual behavior in male rats.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.